thom_tillis1CHAPEL HILL–U.S. Senator Thom Tillis is getting an up close look at the fight against HIV and AIDS.

He toured UNC’s Genetic Medicine Building on Wednesday. This month, UNC-Chapel Hill announced a public-priave partnership with pharmaceutical company GlaxoSmithKline.

The two will work together to find a cure of HIV/AIDS. Much of the lab work will be at the Genetic Medicine Building.

“This means a lot not only to the state but also to the world with 36 million people affected with HIV,” said Sen. Tillis.

School leaders would like him to push Washington to increase funding. The school receives millions of dollars in federal funding through the National Institutes of Health.

“Biomedical research is a public good and it is important that the public fund or otherwise, it will not reach its full promise,” said Dr. William Roper, Dean of the UNC School of Medicine.

“When we find a cure for HIV, it freezes up so many other resources to cure so many other diseases that the nation faces and the world faces” said Tillis.

Tillis will tour other institutions to assess any needs before heading back to Washington.

– Chris Williams